Anbio Biotechnology (NASDAQ:NNNN) Shares Down 8.6% – What’s Next?

by · The Cerbat Gem

Shares of Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) were down 8.6% during mid-day trading on Friday . The stock traded as low as $6.61 and last traded at $6.70. Approximately 21,627 shares changed hands during trading, a decline of 59% from the average daily volume of 53,030 shares. The stock had previously closed at $7.33.

Analyst Ratings Changes

Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Check Out Our Latest Stock Report on Anbio Biotechnology

Anbio Biotechnology Trading Down 1.5%

The company has a fifty day simple moving average of $11.55 and a two-hundred day simple moving average of $20.74.

About Anbio Biotechnology

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.

Read More